Performances of Prognostic Models in Stratifying Patients with Advanced Gastric Cancer Receiving First-line Chemotherapy: a Validation Study in a Chinese Cohort
Open Access
- 1 January 2021
- journal article
- research article
- Published by The Korean Gastric Cancer Association in Journal of Gastric Cancer
- Vol. 21 (3) , 268-278
Abstract
Xu H, et al. J Gastric Cancer. 2021 Sep;21:e26. https://doi.org/10.5230/jgc.2021.21.e26Keywords
Funding Information
- Anhui Provincial Key Research and Development Program (1804b06020351)
- the First Affiliated Hospital of Anhui Medical University (LCYJ2021YB015)
- Hefei Municipal Health Commission (hwk2018yb03)
This publication has 21 references indexed in Scilit:
- Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START)Journal of Cancer Research and Clinical Oncology, 2013
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 2010
- Validation of the Royal Marsden Hospital Prognostic Index in Advanced Esophagogastric Cancer Using Individual Patient Data From the REAL 2 StudyJournal of Clinical Oncology, 2009
- Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trialAnnals of Oncology, 2009
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trialThe Lancet Oncology, 2008
- Capecitabine and Oxaliplatin for Advanced Esophagogastric CancerNew England Journal of Medicine, 2008
- Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapyCancer Chemotherapy and Pharmacology, 2007
- Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinomaAnnals of Oncology, 2007
- Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study GroupJournal of Clinical Oncology, 2006
- Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer—Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Individual Patient DataJournal of Clinical Oncology, 2004